1. p‑STAT3 influences doxorubicin and etoposide resistance of A549 cells grown in an in vitro 3D culture model
   Siriporn Keeratichamroen et al, 2023, Oncology Reports CrossRef
2. Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
   S Zhou et al, 2014, British Journal of Cancer CrossRef
3. CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
   Erika Ortolan et al, 2014, Oncotarget CrossRef
4. Malignant Mesothelioma: Development to Therapy
   Joyce K. Thompson et al, 2014, Journal of Cellular Biochemistry CrossRef
5. ERK/RSK-mediated phosphorylation of Y-box binding protein-1 aggravates diabetic cardiomyopathy by suppressing its interaction with deubiquitinase OTUB1
   Xiaodan Zhong et al, 2022, Journal of Biological Chemistry CrossRef
6. Overcoming IGF1R/IR Resistance through Inhibition of MEK Signaling in Colorectal Cancer Models
   Sara A. Flanigan et al, 2013, Clinical Cancer Research CrossRef
7. Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway
   Pengfei Shi et al, 2014, BMC Cancer CrossRef
8. The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints
   Giulia M. Stella et al, 2023, International Journal of Molecular Sciences CrossRef
9. MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
   Rajani Kanteti et al, 2014, PLoS ONE CrossRef
10. All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism
    Reyna Sara Quintero Barceinas et al, 2015, BioMed Research International CrossRef